Skip to main content
. 2023 Mar 27;15(7):2000. doi: 10.3390/cancers15072000
CDK4/6i cyclin-dependent kinases 4/6 inhibitors
HCWs healthcare workers
AEs adverse events
BL baseline
1D first vaccine dose
2D second vaccine dose
RUs relative units
AUs arbitrary units
BAUs binding antibody units
INF interferon
PBMC peripheral blood mononuclear cell
PBS phosphate-buffered saline
FBS fetal bovine serum
DMSO dimethyl sulfoxide
Rb retinoblastoma